Propranolol as first-line treatment for rapidly proliferating Infantile Haemangiomas (Q84960775)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20797926%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20797926%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Propranolol as first-line treatment for rapidly proliferating Infantile Haemangiomas (English)

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

2 July 2024

author name string

W. J M. Holmes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20797926

2 July 2024

A. Mishra

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20797926

2 July 2024

C. Gorst

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20797926

2 July 2024

S. H. Liew

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20797926

2 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20797926

2 July 2024

publication date

24 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20797926%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

12 February 2020

https://api.elsevier.com/content/article/PII:S1748681510004195?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

https://api.elsevier.com/content/article/PII:S1748681510004195?httpAccept=text/plain

2 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Journal of Plastic, Reconstructive and Aesthetic Surgery

2 July 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20797926%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20797926%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20797926%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

445-451

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20797926%20AND%20SRC:MED&resulttype=core&format=json

Superficial hemangiomas: associations and management

12 February 2020

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Infantile hemangioma. Successful treatment with propranolol

2 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Propranolol therapy for infantile haemangiomas: review of the literature

2 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Propranolol for severe hemangiomas of infancy.

2 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA.

2 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development.

2 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Classification and management of the various superficial vascular anomalies: hemangiomas and vascular malformations

2 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Response of ulcerated perineal hemangiomas of infancy to becaplermin gel, a recombinant human platelet-derived growth factor

2 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Guidelines of care for hemangiomas of infancy

2 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation

2 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Complications of systemic corticosteroid therapy for problematic hemangioma

2 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas

2 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Prevalence of adrenal insufficiency following systemic glucocorticoid therapy in infants with hemangiomas

2 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma.

2 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Current Opinion in Otolaryngology & Head and Neck Surgery

2 July 2024

17

author name string

Buckmiller

publication date

2009

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Propranolol as first-line treatment for infantile hemangiomas

2 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Propranolol for severe infantile hemangiomas: follow-up report

2 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Response to oral propranolol therapy for ulcerated hemangiomas in infancy

2 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Life-threatening infantile haemangioma: a dramatic response to propranolol.

2 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Massive response of severe infantile hepatic hemangioma to propanolol

2 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Propranolol for isolated orbital infantile hemangioma

2 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

2 July 2024

Hemangiomas of infancy.

28

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Beta-blocking agent for treatment of infantile hemangioma.

2 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Propranolol in prevention of portal hypertensive hemorrhage in children: a pilot study

2 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Patient acceptability of propranolol and the occurence of side effects

2 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Are 1-2 tablets dangerous? Beta-blocker exposure in toddlers

2 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Propranolol treatment for hemangioma of infancy: risks and recommendations

2 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action

2 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system

2 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Cellular markers that distinguish the phases of hemangioma during infancy and childhood

2 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Cellular and extracellular markers of hemangioma

2 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Sympathetic control of VEGF angiogenic signaling: dual regulations by alpha 2-adrenoceptor activation?

2 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Norepinephrine induces vascular endothelial growth factor gene expression in brown adipocytes through a beta -adrenoreceptor/cAMP/protein kinase A pathway involving Src but independently of Erk1/2

2 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression

2 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma

2 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.BJPS.2010.07.009

2 July 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20797926%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference